BNP Paribas UK News
September 9, 2021 - ,

Exane BNP Paribas ranked number 1 research provider in Developed Europe for the 5th year running in the European Institutional Investor (II) survey results

Forward to a friendForward to a friend PrintPrint

London Thursday 9 September 2021 – Exane BNP Paribas has maintained its position as number 1 research provider for Developed Europe for the 5th year running in the 2021 European Institutional Investor (II) survey results for Research & Specialist Sales

This top performance confirms Exane BNP Paribas’ position as the leading platform in European equities.

Key highlights for Exane BNP Paribas from yesterday’s results: 

  • #1 Developed Europe Research – the main headline category
  • #1 Industry Research – including 16 Number 1 rankings out of 30 sectors
  • #1 for Ranked Analysts – with 44 Top 3 or Runner-Up positions
  • Specialist Sales ranked Top 3 Positions in 24 categories (out of a possible 31)

Ben Spruntulis, head of cash equities at Exane BNP Paribas commented: “We are delighted that our clients have once again ranked Exane BNP Paribas as Europe’s top research provider for Developed Europe. It takes a huge team effort to succeed in such a competitive environment and it’s even more impressive to deliver so consistently, maintaining the top spot for five consecutive years. We’re proud to see the hard work and dedication of our exceptional people recognised in our industry’s definitive survey, and grateful to our clients for their continued support.”

Renaud-Franck Falce, head of capital markets in EMEA at BNP Paribas said: “We are proud of our Equity franchise that is known to our Corporate and Institutional clients for its outstanding performance once again this year. We are actively leveraging our partnership across Equities and Banking activities to deliver for our clients in an exceptionally busy period in Equity Capital Markets and will continue to strengthen such partnership thanks to the integration of Exane BNP Paribas.”

Nicolas Marque, global head of equity derivatives at BNP Paribas remarked:

“The result of this year’s Institutional Investor Developed Europe survey marks another key milestone following our acquisition of Exane earlier this year. Across Execution, Distribution & Advisory, we have a top platform and clear client recognition for our franchise. The Exane acquisition has a key role to play in building a great global equities business.”

 

Press Contacts

Emily Osborne

emily.osborne@uk.bnpparibas.com

+447469403814

BNP Paribas CIB on Twitter – @BNPParibasCIB

 

Notes to editors:

About BNP Paribas

BNP Paribas is a leading bank in Europe with an international reach. It operates in 68 countries and has more than 193,000 employees, including nearly 148,000 in Europe. The Group has key positions in its three main activities: Domestic Markets and International Financial Services (whose retail-banking networks and financial services are covered by Retail Banking & Services) and Corporate & Institutional Banking, which serves two client franchises: corporate clients and institutional investors. The Group helps all its clients (individuals, community associations, entrepreneurs, SMEs, corporates and institutional clients) to realise their projects through solutions spanning financing, investment, savings and protection insurance. In Europe, the Group has four domestic markets (Belgium, France, Italy and Luxembourg) and BNP Paribas Personal Finance is the European leader in consumer lending. BNP Paribas is rolling out its integrated retail-banking model in Mediterranean countries, in Turkey, in Eastern Europe and a large network in the western part of the United States. In its Corporate & Institutional Banking and International Financial Services activities, BNP Paribas also enjoys top positions in Europe, a strong presence in the Americas as well as a solid and fast-growing business in Asia-Pacific.

-Ends-